Friday, October 18, 2019
| 0715 | Registration and continental breakfast |
| 0755 |
Welcome remarks Sender Herschorn |
| Endourology | Moderator: Kenneth Pace (Each presentation will have a min of 7.5 minutes of interactivity btw audience and speaker) |
| 0800 |
Quality assessment in Urology and endourology: What can Canada learn from the USA? Dr. T. Averch The asymptomatic stone: Observe or treat? |
| 0830 |
A 6mm upper calyceal stone in a woman about to undergo IVF Treat: Dr. M. Farcas Discussion |
| 0900 |
A 4mm lower calyceal stone in a pilot Treat: Dr. T. Averch Discussion |
| 0930 |
A 12 mm lower calyceal stone in a comorbid 80 y.o. woman with a history of struvite stones Treat: Dr. M. Ordon Discussion |
| 1000 | Break with Exhibitors |
| Endourology and stones | Moderator: Kenneth Pace (Each presentation will have a min of 5 minutes of interactivity btw audience and speaker) |
| 1030 |
A practical approach to stone metabolic workup Dr. T. Averch |
| 1050 |
New technologies in Endourology Dr. M. Farcas |
| 1115 | Panel discussion with audience |
| Intraoperative urologic injuries: Getting out of trouble |
Moderator: Sender Herschorn (Each presentation will have a min of 2 minutes of interactivity btw audience and speaker) |
| 1115 |
How I handle ureteroscopic injuries Dr. M. Ordon |
| 1125 |
Update on iatrogenic ureteral injuries Dr. B. Brucker |
| 1135 |
Bladder injuries during ob-gyn surgery Dr. S. Herschorn |
| 1145 |
Recognizing and treating urethral injuries during urologic surgery Dr. S. Radomski |
| 1155 | Case Presentation, Panel and Discussion with Audience |
| 1215 | Lunch with exhibitors |
| Neurogenic lower urinary tract dysfunction | Moderator: Sender Herschorn (Each presentation will have a min of 3 minutes of interactivity btw audience and speaker) |
| 1300 |
Review of pathophysiology, epidemiology, and new classification of NLTD Dr. S. Herschorn |
| 1315 |
Initial workup and risk stratification in new CUA Guidelines Dr. L. Stothers |
| 1330 | Common urologic problems and their management with: Diseases at the brainstem and above (CVA, CP, Parkinson’s)Dr. S. Radomski |
| 1345 |
Diseases of the spinal cord (MS, SCI) Dr. B. Brucker |
| 1400 |
Diseases distal to the spinal cord (disk disease, radical pelvic surgery) Dr. S. Herschorn |
| 1415 |
Update on urinary tract infection in patients managed with indwelling or intermittent catheterization Dr. L. Stothers |
| 1430 |
Cases and discussion Panelists: B. Brucker, S. Radomski, L. Stothers |
| 1500 | Break with exhibitors |
| Pediatric urology | Moderator: Armando Lorenzo (Each presentation will have a min of 5 minutes of interactivity btw audience and speaker) |
| 1530 |
Quality Improvement in Pediatric Urology: ‘Collaboration of specialized and community centres in uncommon surgical problems. Dr. P. Merguerian |
| 1555 |
Digital photography and artificial intelligence: What every urologist should know (and expect) about the future Dr. D. Bagli |
| 1620 | Update on management of sexual dysfunction in adolescents: Persistent curvature after hypospadias repair Vaginal stenosis after urogenital procedures Neurogenic sexual dysfunctionPanelists: Drs. D. Bagli, Y. Krakowski, P. Merguerian |
| 1700 | Adjourn |
Saturday, October 19, 2019
(Each presentation will include a 25% min interactivity btw speaker and audience)
| 0715 | Registration and continental breakfast |
| Prostate Cancer: Localized | Moderator: Neil Fleshner (Each presentation will have a min of 3 minutes of interactivity btw audience and speaker) |
| 0800 |
Novel biomarkers in the management of localized prostate cancer: Canadian perspective Dr. A. Zlotta |
| 0815 |
Are all Grade Group 1 tumours the same? Implications for active surveillance and focal therapy Dr. M. Cooperberg |
| 0835 |
5-ARI’s and prostate cancer: novel developments Dr. R. Hamilton |
| 0850 |
Role of MRI in staging high risk prostate cancer Dr. N. Perlis |
| 0905 |
High risk and very high risk prostate cancer: workup and optimal management Dr. B. Chapin |
| 0925 |
Case presentations and discussion Panel: Drs. A. Zlotta, N. Perlis, B. Chapin, M. Cooperberg |
| 1000 | Break with Exhibitors |
| Kidney Cancer | Moderator: Nathan Perlis (Each presentation will have a min of 3 minutes of interactivity btw audience and speaker) |
| 1030 |
Necessity of renal hypothermia during partial nephrectomy – results from randomized trial Dr. R. Breau |
| 1045 |
Practical tips in the active surveillance of small renal masses Dr. M. Jewett |
| 1100 | Systemic therapy for advanced renal cell carcinoma: Take away points for the practicing urologist Dr. R. Breau |
| Hyperbaric medicine | Moderator: Robert Hamilton |
| 1115 |
Update on hyperbaric oxygen for the urologic patient Dr. W. Evans |
| 1140 | Presentation discussion with presenter and audience |
| Surgical Safety in the OR | Moderator: Sender Herschorn |
| 1145 |
Is the operating room as safe as it can be? Lessons from our medico-legal files Dr. G. Lefebvre |
| 1230 | Presentation discussion with presenter and audience |
| 1245 | Lunch with exhibitors |
| Bladder Cancer | Moderator: Alexandre Zlotta (Each presentation will have a min of 3 minutes of interactivity btw audience and speaker) |
| 1330 |
Vincent Colapinto Memorial Lecture Introduction by Michael Jewett Dr. M. O’Donnell |
| 1400 |
Improving outcomes of Radical Cystectomy: ERAS and beyond Dr. N. Fleshner |
| 1415 |
Managing the BCG shortage: Updates and new option Dr. M. O’Donnell |
| 1430 |
Case presentations and discussion with audience Panel: Drs. M. O’Donnell, M. Jewett, N. Fleshner, R. Breau |
| 1500 | Break with exhibitors |
| Prostate Cancer | Moderator: Robert Hamilton |
| 1530 |
Functional imaging in metastatic prostate cancer: when and in whom? Dr. M. Cooperberg |
| 1550 |
Management of oligometastatic prostate cancer in 2019: Role of radiation versus surgery Dr. P. Cheung |
| 1610 |
Cytoreductive prostatectomy: treatment of the primary tumour in hormone sensitive metastatic prostate cancer Dr. B. Chapin |
| 1630 |
Cardiovascular risks of androgen deprivation: New insights on androgen-receptor-axis-targeted therapies Dr. N. Fleshner |
| 1645 | Case presentations discussion with presenter and audience |
| 1700 | Adjourn |